2005
DOI: 10.1038/sj.gt.3302673
|View full text |Cite|
|
Sign up to set email alerts
|

Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
47
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(47 citation statements)
references
References 72 publications
0
47
0
Order By: Relevance
“…One of the earliest and still major strategies used for delivery involves virus-based vectors, including retroviruses, adenoviruses, and adeno-associated viruses, which have been modified to carry engineered payloads and cell-targeting elements (79,80). Self-assembled virus-like particles (VLPs) and virosomes (virion-like phospholipid bilayer vesicles with surface glycoproteins) can also carry biomolecular cargo (81,82). Such delivery modes are quite promising, and some have been approved for use in humans.…”
Section: In Vivo Diagnosticsmentioning
confidence: 99%
“…One of the earliest and still major strategies used for delivery involves virus-based vectors, including retroviruses, adenoviruses, and adeno-associated viruses, which have been modified to carry engineered payloads and cell-targeting elements (79,80). Self-assembled virus-like particles (VLPs) and virosomes (virion-like phospholipid bilayer vesicles with surface glycoproteins) can also carry biomolecular cargo (81,82). Such delivery modes are quite promising, and some have been approved for use in humans.…”
Section: In Vivo Diagnosticsmentioning
confidence: 99%
“…328 Virosomes reconstituted from viral lipids and proteins have been also used to encapsulate small interfering RNA ( siRNA). 329 They have also gained attention as potential drug and gene delivery carriers, owing to their ease of production and modification as well as their low toxicity. 330 Their in vivo applications for drug delivery, however, are limited by the potential risk of immunogenicity.…”
Section: Nanomedicines Based On Hybrid Biomimetic Systemsmentioning
confidence: 99%
“…Modified virus envelopes can be adapted to deliver nucleic acids to cells. Fusogenic influenza virus envelopes were used to deliver fluorescent dye-labeled siRNAs by IP injection in mice [186], hemagglutinating virus of Japan (HVJ) envelopes were used to deliver siRNAs via direct intratumor injection in mice [187], and SV40 pseudovirions are being tested as a delivery vehicle [188]. These delivery tools and other potential ligands such as mannose and aptamers [151] will need careful evaluation for efficacy and potential antigenicity if they are to be considered for therapeutic applications.…”
Section: Other Cell Targeting Ligandsmentioning
confidence: 99%